Brinckerhoff Quoted on Myriad Ruling

31 July 2011 Pharmacogenomics Reporter News

Foley Partner Courtenay Brinckerhoff was quoted in an article that appeared in Pharmacogenomics Reporter on July 31, 2011 titled "Appeals Court Decides Isolated DNA Patentable, Myriad's Analytical Method Claims Not." Brinckerhoff discusses the Court of Appeals for the Federal Circuit’s ruling that isolated gene sequences are patentable, stating that the decision could have a far-reaching impact on other patents and personalized medicine type claims. She adds that practitioners and patent holders may want to review pending and granted claims to determine if they are affected by recent decisions regarding gene patent eligibility.

Related Services


Review of Recent Whistleblower Developments
30 July 2021
Legal News: Whistleblower Developments
$4.24M Now the Average Cost Per Data Breach!
30 July 2021
Internet, IT & e-Discovery Blog
Podcast Episode 56: All Things Summer Associate Recruiting
30 July 2021
Foley Career Perspectives
Foley Podcast to Live Panel Discussion
29 July 2021
Foley Career Perspectives
30th Annual Law of Product Distribution & Franchise Seminar
29 September | 7 & 20 October 2021
Milwaukee | Chicago | Dallas
7th National Telehealth Summit
4-5 October 2021
Miami Beach, FL
AHLA Fraud & Compliance Forum
21-22 September 2021
Baltimore, MD
2nd Clinical Trial Agreements Forum
16-17 September 2021
Online Livestream